The CEO's cashless option exercise and same-day sale is a standard compensation-related transaction, not a bearish signal. The cluster size is immaterial relative to UTHR's $22.1B market cap. Monitor the upcoming PDUFA for Tyvaso in IPF and the ralinepag NDA review as the real catalysts; this insider activity has no incremental trading signal.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 13 $501.27entry
- T+1 · 3mo ago −0.31%α −0.11% · $499.73
- T+5 · 3mo ago +3.94%α +5.90% · $521.00
- T+20 · 2mo ago −0.83%α +0.92% · $497.11
- T+60 · 11d ago +12.12%α +17.59% · $562.02
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
CEO Martine Rothblatt executed a large option exercise and sold a significant block of shares (net ~$6.4M in open-market sales) on August 11, 2026, just one week after the company reported Q2 revenue that missed consensus. EVP & General Counsel Paul Mahon also sold $404K on August 6. The total open-market sales of ~$1.03M (cluster total) represent ~0.005% of UTHR's $22.1B market cap, a trivial amount. However, the CEO's pattern of exercising 9,500 options at $135.42 and immediately selling the shares at ~$520 is a classic cashless exercise, not a bearish conviction sale. The cluster is routine in size and structure, with no material information signal beyond the already-disclosed earnings miss.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt exercised 9,500 options at $135.42 and sold 9,500 shares at ~$520 in a cashless exercise on Aug 11, 2026
- Total open-market sales by CEO: ~$6.4M across 18 transactions on Aug 11
- EVP & General Counsel Paul Mahon sold 780 shares for $404K on Aug 6
- Total cluster open-market sales: ~$1.03M, or ~0.005% of $22.1B market cap
- Q2 2026 revenue of $783.3M missed $804.6M consensus, down 2% YoY
Financial Impact
Total insider open-market sales of ~$1.03M represent 0.005% of market cap, trivial and routine
Risk Factors
- Tyvaso franchise facing competitive headwinds in inhaled prostacyclin class
- Revenue decline of 2% YoY in Q2 2026 may signal slowing growth for the core product
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1786608191145 |
Track record
123 reports on UTHR
4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
- Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
- Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers